Beradio, Javelene Q.
HRN: 03-68-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/19/2022
CEFUROXIME 1.5GM (VIAL)
09/19/2022
09/20/2022
IV
1.5g
Q8
T/C UTI
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines